Antibiotic Use in COPD Exacerbations

Introduction to Antibiotic Selection

The European Respiratory Society and American Thoracic Society conditionally recommend antibiotics for ambulatory COPD exacerbations, reducing treatment failure and prolonging time to next exacerbation by 73 days, with a strength of evidence rated as moderate 3

Antibiotics are recommended for ambulatory patients with COPD exacerbations presenting with purulent sputum, as this is 94% sensitive and 77% specific for high bacterial load, according to the European Respiratory Society 1, 2
For hospitalized patients with severe COPD, antibiotics should be administered, as most have Type I or II exacerbations according to Anthonisen criteria, with a high strength of evidence 1, 2
Patients requiring mechanical ventilation must receive antibiotics, as withholding them leads to adverse outcomes and increased secondary infections, with a high strength of evidence 1, 2

Ceftriaxone can be used for hospitalized COPD exacerbations in patients without Pseudomonas risk factors, with good activity against common COPD pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 4, 5
However, ceftriaxone has no activity against Pseudomonas aeruginosa, despite being a broad-spectrum third-generation cephalosporin, with a high strength of evidence 4, 5, 6

Recent hospitalization is a risk factor for Pseudomonas infection in COPD exacerbations 2
Frequent antibiotic use, severe COPD, and prior isolation of P. aeruginosa are also risk factors for Pseudomonas infection 1, 2

Amoxicillin-clavulanate and respiratory fluoroquinolones are preferred alternatives for hospitalized COPD exacerbations, offering broader coverage and excellent bronchial penetration 4, 5

Antibiotic treatment should be maintained for 7-10 days on average, with the oral route preferred if the patient can tolerate oral intake 4, 5
Shorter courses of 5 days with levofloxacin or moxifloxacin have shown equivalent efficacy to 10-day beta-lactam courses, with a moderate strength of evidence 4, 5, 7